Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Telehealth shift during COVID-19 pandemic shows capacity to safely deliver cardiology care Darlene Dobkowski, MA; Regina Schaffer
• Rapid bedside genetic testing enhances safety, efficacy of antiplatelet therapy Robert Roberts, MD, FRSC, FRCPC, MACC, LLD (Hon.), FAHA
• Acute MI fatality rate higher than expected during COVID-19 pandemic Erik Swain
• Aspirin only post-TAVR reduces bleeding vs. aspirin plus clopidogrel: POPULAR TAVI Scott Buzby
• Beta-blockers may increase HF risk in women with new-onset CHD Darlene Dobkowski, MA
• Patient sex, race may impact decision-making for heart transplant, VAD allocation Scott Buzby
• CABANA: Catheter ablation reduces AF recurrence through 5 years Darlene Dobkowski, MA
• Consuming chocolate once per week may decrease CAD risk Darlene Dobkowski, MA
• Combination therapy reduces risk for abnormalities, treatment failure in Kawasaki disease Darlene Dobkowski, MA
• Dapagliflozin cuts renal, CV events in CKD, regardless of diabetes status Katie Kalvaitis
• EAST-AFNET 4: Early rhythm control for AF reduces risk for poor CV outcomes Darlene Dobkowski, MA
• In high-risk younger patients, cholesterol guideline suitability questioned Darlene Dobkowski, MA; Erik Swain
• LoDoCo2: Low-dose colchicine reduces CV events by 31% on top of optimal medical therapy Erik Swain
• No clinical benefit of ACE inhibitor, ARB suspension in mild to moderate COVID-19 Katie Kalvaitis
• ACC: Cardiologists can use novel therapies to lower CV risk in type 2 diabetes Darlene Dobkowski, MA
• AHA: Evidence suggests no CV benefit, possible harm from cannabis use Erik Swain
• Younger women with PCOS at elevated risk for CVD Erik Swain
• A ‘chicken or egg’ problem: Targeting timing of CV complications in type 2 diabetes Regina Schaffer
• Empagliflozin lowers CV death, hospitalizations in HFrEF with or without diabetes Katie Kalvaitis
• Limiting sugar-sweetened beverage consumption may lower cardiometabolic risks Darlene Dobkowski, MA
• ALLSTAR
• EVACS
• ISAR-REACT 5
• SDM4AFIB